KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Match (MTCH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Match (MTCH) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Match's Cash & Equivalents rose 2310.94% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 2310.94%. This contributed to the annual value of $966.0 million for FY2024, which is 1200.7% up from last year.
  • According to the latest figures from Q3 2025, Match's Cash & Equivalents is $1.1 billion, which was up 2310.94% from $335.2 million recorded in Q2 2025.
  • Over the past 5 years, Match's Cash & Equivalents peaked at $1.1 billion during Q3 2025, and registered a low of $236.5 million during Q2 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $732.6 million (2023), whereas its average is $683.8 million.
  • As far as peak fluctuations go, Match's Cash & Equivalents surged by 9609.49% in 2022, and later tumbled by 5998.49% in 2025.
  • Match's Cash & Equivalents (Quarter) stood at $815.4 million in 2021, then decreased by 29.8% to $572.4 million in 2022, then soared by 50.67% to $862.4 million in 2023, then rose by 12.01% to $966.0 million in 2024, then grew by 9.03% to $1.1 billion in 2025.
  • Its Cash & Equivalents stands at $1.1 billion for Q3 2025, versus $335.2 million for Q2 2025 and $409.4 million for Q1 2025.